Results 231 to 240 of about 191,930 (288)

Association between adiposity and psoriatic arthritis beyond classical clinical predictors. [PDF]

open access: yesClin Rheumatol
Pardo E   +5 more
europepmc   +1 more source

Recent Advances (2023–2025) of Capillary Electrophoresis‐Mass Spectrometry (CE‐MS) for Top‐Down Proteomics

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Top‐down proteomics (TDP) characterizes proteoforms in cells, tissues, and biofluids, in discovery mode and on a global scale, requiring analytical tools with high peak capacity for proteoform separation and high sensitivity for proteoform detection, given the extremely high proteoform complexity and wide proteoform concentration dynamic range.
Guijie Zhu   +5 more
wiley   +1 more source

Predicting disease progression and mortality in prostate cancer using real-world data-driven time-inhomogeneous Markov models. [PDF]

open access: yesiScience
Wang J   +10 more
europepmc   +1 more source

[<sup>18</sup>F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer. [PDF]

open access: yesInt J Urol
Hatano K   +15 more
europepmc   +1 more source

Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase. [PDF]

open access: yesRheumatology (Oxford)
Macleod T   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

SERUM-PSA, F/T PSA, PSAD, PSA-TZ AND PSA VELOCITY

The Journal of Urology, 1999
The clinical value of prostate-specific antigen (PSA) density in differentiating between prostate cancer and benign prostatic hyperplasia has been the subject of several studies. In this context the question has been raised about the diagnostic benefit of PSA transition-zone density (PSA-TZ density = total PSA/transition-zone volume) in the detection ...
Bob Djavan   +5 more
openaire   +3 more sources

Impact of race and baseline PSA on longitudinal PSA

International Journal of Cancer, 2005
AbstractThere is an increasing debate regarding the frequency of prostate‐specific antigen (PSA) testing and the current primary screening modality used to detect prostate cancer. The purpose of this study is to determine whether PSA screening intervals should be based on initial PSA.
Katharine, McGreevy   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy